The cost-effectiveness of the use of clopidogrel in acute coronary syndromes in five countries based upon the CURE study

This publication has 7 references indexed in Scilit:

• Benefit of Clopidogrel in Patients With Acute Coronary Syndromes Without ST-Segment Elevation in Various Risk Groups
  Circulation, 2002
• Contemporary Evaluation and Management of Hypertrophic Cardiomyopathy
  Circulation, 2002
• Cost effectiveness of eptifibatide in acute coronary syndromes. An economic analysis of Western European patients enrolled in the PURSUIT trial
  Published by Oxford University Press (OUP) ,2002
• Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians
  Statistics in Medicine, 2000
• Cost-Effectiveness of Platelet Glycoprotein IIb/IIIa Inhibition With Eptifibatide in Patients With Non–ST-Elevation Acute Coronary Syndromes
  Circulation, 2000
• Economic assessment of tirofiban in the management of acute coronary syndromes in the hospital setting; an analysis based on the PRISM PLUS trial
  European Heart Journal, 1999
• Economic Assessment of Low-Molecular-Weight Heparin (Enoxaparin) Versus Unfractionated Heparin in Acute Coronary Syndrome Patients
  Circulation, 1998